Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
206 articles
New research reveals how blood factors trigger muscle weakness in autoimmune disease and identifies potential therapeutic targets.
Breakthrough study shows CAR T-cell therapy normalizes neutrophil function in lupus, offering new hope for autoimmune treatment.
New study reveals specific immune and microbiome signatures that could predict depression in lupus patients with 85% accuracy.
Scientists use human blood vessel organoids to decode the progression of systemic sclerosis, revealing new therapeutic targets.
Updated EULAR recommendations provide comprehensive management strategies for this complex autoimmune condition affecting multiple organs.
New research reveals progress in lupus pregnancy care while highlighting persistent medication and outcome disparities.
Researchers developed accurate diagnostic codes to identify arthritis caused by cancer immunotherapy drugs.
Researchers identified specific lupus patient subgroups who respond dramatically better to baricitinib using gene expression analysis.
Whole genome sequencing of 7,339 Chinese participants uncovers novel genetic variants affecting serum uric acid, opening doors for precision therapies.
Combination therapy with guselkumab and golimumab improved joint symptoms in patients who failed previous treatments.
PFAS exposure associated with 55% higher odds of developing symptomatic knee osteoarthritis over 4 years.
Swedish study reveals significant improvements in pregnancy safety for women with systemic lupus erythematosus over 20 years.
